Archive for the ‘Lyme’ Category

How Common is Lyme Carditis in Patients Referred For Pacemaker Implantation?

https://danielcameronmd.com/lyme-carditis-in-patients-pacemaker-implantation/

HOW COMMON IS LYME CARDITIS IN PATIENTS REFERRED FOR PACEMAKER IMPLANTATION?

Doctor looking at ECG machine to diagnose lyme carditis in patient admitted for a pacemaker.

Atrioventricular blocks (AVBs) due to an infection have rarely been reported. However, “Borrelia burgdorferi is increasingly noted as responsible for a considerable number of infection-related AVBs, and AVBs have been reported as the most common clinical presentation of [Lyme carditis],” according to the authors of a newly published study.

By Dr. Daniel Cameron

In the study “Prevalence of Lyme Carditis in Patients with Atrioventricular Blocks,” Kaczmarek and colleagues aim to identify patients in whom Lyme carditis (LC) should be considered as the underlying cause of AV conduction disturbances.¹

Investigators examined 130 patients with AVB who had been consecutively admitted over a 12-month period, to the Department of Electrocardiology Medical University of Lodz, Poland, for implantation of a permanent pacemaker.

All of the patients underwent serological testing for Borrelia burgdorferi sensu lato (Bbsl).

The majority of the patients had arterial hypertension (64.6%), approximately 1 in 4 had ischemic heart disease (26.2%) and 1 in 5 suffered from diabetes (19.9%) and dyslipidemia (21.9%).
“Atrial fibrillation was reported by 23 patients (17.7%). One sixth (22; 16.9%) of the patients had a history of heart failure, including 13 individuals (10.0%) with a reduced and mildly reduced ejection fraction,” according to Kaczmarek et al.

Lyme carditis in patients admitted for pacemaker implants

Out of the 130 patients, 30 (23.1%) individuals tested positive for Borrelia burgdorferi, the causative agent of Lyme disease. “IgM seropositivity indicating acute phase was found in 16 of them (12.3%), which together with clinical scenario of AVB led to initial diagnosis of LC.”

The authors found that Lyme carditis was assumed as the initial diagnosis in 16 patients based on ABV and IgM Bbsl seropositivity.

In 10% of these patients, Lyme carditis was identified as the potential cause of AV conduction disturbances.

“In clinical practice, patients with [Lyme carditis] diagnosis at admission typically receive antibiotics, which seem to be highly effective in resolving advanced atrioventricular conduction abnormalities.”

The clinical characteristics were similar between the Lyme carditis and non-LC group. Nearly 40% of patients in both groups had complete heart block, while second-degree AVB was identified in over 50% of patients in the LC and non-LC group.

The patients did not exhibit any signs or symptoms of acute myocarditis or endocarditis. “Therefore, the atrioventricular conduction disturbances were found to be the unique clinical presentation of [Lyme carditis] in our study group.”

Additionally, Lyme carditis patients were younger and more often exhibited constitutional symptoms of infection, along with fluctuating atrioventricular conduction abnormalities.

Authors Conclude:

  • “Lyme carditis should be considered as the initial diagnosis in a relatively high number of patients (8%) admitted with atrioventricular blocks for a permanent pacemaker implantation.”
  • “The prevalence of LC was even higher (12%) in the patients without obvious causes of a cardiac conduction system dysfunction.”
  • “We confirmed that the fluctuating nature of AVBs reported previously in case reports should be taken into account as a strong predictor of LC in patients referred for a pacemaker implantation.”
  • “We suggest that atrioventricular conduction behavior observed on ECG monitoring should be included in the diagnostic process of AVBs that could be potentially [Lyme carditis-related].”
Related Articles:

Lyme carditis presenting as atrial fibrillation treated successfully

Another cardiac manifestation of Lyme myocarditis

Lyme myocarditis in patient with no other signs of Lyme disease

References:
  1. Kaczmarek KA, Szwabe K, Urbanek I, Ptaszynski P, Strzelecki A, Wranicz JK, Cygankiewicz I. Prevalence of Lyme Carditis in Patients with Atrioventricular Blocks. International Journal of Environmental Research and Public Health. 2022; 19(22):14893. https://doi.org/10.3390/ijerph192214893

_______________

**Comment**

Imagine all the patients who are seronegative who are kicked to the curb even though they very well may have Lyme carditis and would improve or become well with appropriate treatment.

For more:

Category:

Heart Issues, Lyme, research

Lyme Detox Webinar Tonight

https://rawlsmd.com/webinars/lyme-detox/?utm_source=Klaviyo&utm_medium=email&utm_campaign=webinar

Lyme Detox

How to Use Detox as an Effective Tool for Lyme Recovery

  • Wed. Jan. 18, 2023
  • 8 PM EST

Live Webinar + Q&A: Lyme Detox

Chronic Lyme patients know that following the right detoxification plan is vital to supporting the body’s ability to heal and avoiding or minimizing Herxheimer reactions that commonly occur with microbial die-off. But finding the right plan amidst all the products and programs out there can be downright confusing.

So which detox methods are best for removing toxins like mold, heavy metals, and bacterial die-off from the body, and when is the right time to put a Lyme detox protocol into action? 

Join a live webinar with Dr. Bill Rawls, author of the bestselling book Unlocking Lyme, as he shares a practical and sustainable approach to Lyme detox at a cellular and whole-body level. He’ll discuss his insights on the safest and most effective ways to naturally minimize the inflow of toxins, maximize the outflow, and speed your recovery.

PLUS: Don’t miss an exclusive gift for webinar attendees, and have your questions ready for a LIVE Q&A on Lyme detox with Dr. Rawls.

In This Webinar, Dr. Rawls Will Discuss:

*Environmental toxins that can overtax the body

*How MTHFR mutations and other genetic factors inhibit your ability to flush toxins

*Lifestyle and diet changes that enhance your body’s natural detoxification processes

*The best time to detox in order to optimize your Lyme treatment regimen

*The best herbs and natural supplements to increase toxin outflow

*Numerous insights during the live Q&A with Dr. Rawls

RESERVE MY SEAT »

__________________

For more:

Category:

Activism, Detoxing, diet and nutrition, Gut Health, Herbs, Lyme, Supplements

How the Industrial Medical Complex Promotes Disinformation to Perpetuate an Existing Dogma

Lyme/MSIDS has been in a never-ending time warp. For patients who are educated on the horrific backstory, they were completely aware of COVID madness before most of the public.  The same tricks have been used.  The same fraud, corruption, and lies Lymeland has been dealing with for over 40 years are now finally being seen and felt by the general pubic.

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf

(84%) had no findings of active Lyme disease??

Carl Tuttle

Hudson, NH, United States

JAN 17, 2023 — 

Here is how the industrial medical complex promotes the disinformation to perpetuate an existing dogma. You won’t find any of my references in Dr. Auwaerter’s publication.  Why is that???

Inquiry to Dr. Paul G. Auwaerter

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “pauwaert@jhmi.edu” <pauwaert@jhmi.edu>
Cc: “Takaaki-kobayashi@uiowa.edu” <Takaaki-kobayashi@uiowa.edu>, “yhiggins@jhmi.edu” <yhiggins@jhmi.edu>, “mmelia4@jhmi.edu” <mmelia4@jhmi.edu>, “mwoolley@researchamerica.org” <mwoolley@researchamerica.org>, “jalpert@shc.arizona.edu” <jalpert@shc.arizona.edu>
Date: 01/16/2023 2:57 PM
Subject: Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease
 
The American Journal of Medicine April 2022

Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease (Apr 2022)
https://www.sciencedirect.com/science/article/pii/S0002934321007920
Takaaki Kobayashi MD,  Yvonne Higgins MAS, MS  Michael T.Melia MD  Paul G.Auwaerter MD

Results

“Of 1261 referred patients, 1061 (84%) had no findings of active Lyme disease…”

Paul G. Auwaerter MD
Division of Infectious Diseases
Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, Md

Dear Dr. Auwaerter,

I read your abstract with great interest but I must ask the question; how did you determine that 84% had no findings of active Lyme disease? Were these results obtained through serology?

Seronegative Lyme disease has been reported for years. I have attached a list of publications for your review:

Seronegativity in Lyme borreliosis and Other Spirochetal Infections
(16 September 2003)
https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

For example:

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
____________________________________________

Patients who were featured in the 5min extended trailer for the documentary “Under our Skin” claim the following:

– Misdiagnosed with Chronic Fatigue Syndrome, Lupus, MS, Fibromyalgia, ALS

“Under our Skin” extended trailer (5min)
https://www.youtube.com/watch?v=sxWgS0XLVqw

____________________________________________

Western blot reporting criteria was manipulated in 1995 to facilitate vaccine development. (Dearborn Conference)

That manipulation led to a reduction in diagnostic success rate to 31% as reported by Dr. Paul Fawcett during the 1995 Rheumatology Symposia:

1995 Rheumatology Symposia Abstract# 1254 Dr. Paul Fawcett et al.

View Dr. Paul fawcett’s Abstract 1254 here

Dr. Fawcett has been the head of the research and clinical immunology laboratories since 1986. In addition, he serves as Chair of the IACUC and is a member of the IRB.

Source: https://www.nemoursresearch.org/snap/node/11969

Even more significant is Dennis Parenti’s 1998 vaccine presentation (Lyme.org at 1 hr 9 minutes). Dr. Parenti, medical director of the vaccine trial – the largest Lyme trial in history, discusses the research findings of seronegative Lyme. At 36% it is a common presentation. This proves that a negative western blot is meaningless. Since their patients were culture positive and/or DNA positive for Borrelia infection and western blot negative.
View Dennis Parenti’s 1998 vaccine presentation slide here

As you should know Dr. Auwaerter, serology cannot be used to gauge treatment failure or success so I ask the question again: how did you determine that 84% had no findings of active Lyme disease?

A response to this inquiry is requested.

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Joseph Alpert, MD, MACP Editor-in-Chief, The American Journal of Medicine

Mary Woolley President and CEO of Research!America

Category:

Activism, Lyme, research, Testing

Tick-borne Disease Treatment Study Proposals Needed

https://www.lymectn.org/Pilot.aspx

CTN Tick-borne Disease Pilot Treatment Study Award

We are happy to announce that the Clinical Trials Network established with a grant from the Steven & Alexandra Cohen Foundation to Columbia University announces the third round of Pilot Study Proposal submissions (January 15 to March 15, 2023).

The Clinical Trials Network welcomes clinicians, researchers, and investigators from academic institutions to submit proposals. The proposals are typically 1-3 pages in length, but longer proposals are accepted for review. The CTN’s goal is to support the conduct of small-scale human treatment studies related to treatment of Lyme and other tick-related diseases. These small pilot studies are conducted to determine whether future larger investigations are warranted. Pilot studies often assess safety and feasibility, are exploratory in nature, and are not meant to answer the same questions as larger randomized control trials.

The CTN Study Review Committee will review submissions for consideration for further development into a pilot study; each pilot study will be conducted at one of the CTN investigation sites. The CTN has funding to support 1-2 small pilot studies each year.

Current CTN network affiliates include investigators from Columbia University Irving Medical Center in New York City, Johns Hopkins University Medical Center in Baltimore Maryland, and Children’s National Hospital in Washington D.C. The CTN Study Review Committee includes the core CTN members, clinical research experts, and academic and community clinicians. Results of the CTN pilot studies – if favorable – will lead to consideration for larger Randomized Controlled Trials.

The deadline for the first round of submissions for treatment research ideas from the research scientists and clinicians is March 15, 2023. The submission period opens January 15, 2023.

We thank all clinicians and investigators in advance for participation in this process, as your proposal may lead to a transformative study.

________________
For more:

The fear here is that if this leads to human trials, only those who test positive with an EM rash will qualify, persistent infection will be once again denied, and the continued use of PTLDS will be utilized which will once more omit the sickest patients that are seronegative and without the rash.  This affects everything and hasn’t changed in 40 years.  The entire premise and paradigm is wrong but continues to be utilized in tick-borne disease research.

Category:

Activism, Lyme, Treatment

Royalties & Profits Over Patient Care Part 2

Go here for Part 1.

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf

Patent royalties and pharmaceutical profits over lifesaving care? (Part 2)

Carl Tuttle

Hudson, NH, United States

JAN 12, 2023 — 

We have been shouting from the rooftops for decades!! No one listened.

Now through the current pandemic the rest of the world is waking up to a False Public Health Narrative.

What you are about to read set the stage for “Safe and Effective”

-Manipulated diagnostic tests

-Suppression of the truth, facts, and scientific references

-Persecution of doctors who did not conform to published IDSA treatment protocols

-False Public Health Narrative; “Hard to catch and easy to treat”

After experiencing Covid, Now do you believe us?

Patent royalties and pharmaceutical profits over lifesaving care? Sound familiar?

2nd letter to Dattwyler (See previous update for part1)

——— Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “Raymond_Dattwyler@nymc.edu” <Raymond_Dattwyler@nymc.edu>
Cc: “npjvaccines@nature.com” <npjvaccines@nature.com>, “abarrett@utmb.edu” <abarrett@utmb.edu>, “R.W.Titball@exeter.ac.uk” <R.W.Titball@exeter.ac.uk>, “mgomesso@uthsc.edu” <mgomesso@uthsc.edu>
Date: 01/11/2023 10:46 AM
Subject: Re: The year that shaped the outcome of the OspA vaccine for human Lyme disease
Dr. Dattwyler

As a follow-up to my inquiry questioning patent royalties and pharmaceutical profits over lifesaving care, you failed to mention in your manuscript that Western blot reporting criteria was manipulated in 1995 to facilitate vaccine development. (Dearborn Conference)

That manipulation led to a reduction in diagnostic success rate to 31% as reported by Dr. Paul Fawcett during the 1995 Rheumatology Symposia:

1995 Rheumatology Symposia Abstract# 1254 Dr. Paul Fawcett et al.

See full Abstract here

Dr. Fawcett has been the head of the research and clinical immunology laboratories since 1986. In addition, he serves as Chair of the IACUC and is a member of the IRB.
Source: https://www.nemoursresearch.org/snap/node/11969

Even more significant is Dennis Parenti’s 1998 vaccine presentation (Lyme.org at 1 hr 9 minutes). Dr. Parenti, medical director of the vaccine trial – the largest Lyme trial in history, discusses the research findings of seronegative Lyme. At 36% it is a common presentation. This proves that a negative western blot is meaningless. Since their patients were culture positive and/or DNA positive for Borrelia infection and western blot negative. Those patients would never get treatment because of the false standard. Despite the CDC knowing this, HHS knowing this, physician harassment continued unabated. This means that our own government was cherry-picking scientific findings to force false science on public health and block the public from getting the medical care they needed.

Once again, patent royalties and pharmaceutical profits over lifesaving care.

Slide from Dennis Parenti’s 1998 vaccine presentation:

See slide here_________________________________________________________

Seronegative Lyme does not prove:
1. A vaccine prevented disease:
2. A patient does not have Lyme disease;
3. Malpractice by doctors who treat them for disease;
4. An antibiotic has eradicated the disease;
5. A relapse is not occurring.

Seronegative Lyme is another clue of how the pathogen disables the patient’s immune system. That is the message by the bacterium to researchers, not that the patient does not have Lyme disease.

“Every research study that uses and article referencing seronegative Lyme to indicate any of the above is fraudulent and should not be used. Almost all protocols ignore this fact!!!” -Karen Vanderhoof-Forschner, Lyme Disease Foundation (founded in 1988)

_______________________________________________
The pursuit of patent royalties and pharmaceutical profits has caused unimaginable pain and suffering all across America!
Carl Tuttle
Hudson, NH

Cc: Alan D.T. Barrett, PhD Editor-in-Chief

Rick Titball, PhD, DSc, Deputy Editor

Lyme Disease Foundation
Willy Burgdorfer
Lyme Disease Foundation
Please share as widely as possible, especially to member of state medical licensing boards and state health departments. Remember, Dave Dennis, the cdc Lyme project officer was allowed to consult $$ directly with SKB. He…

Thanks to your support this petition has a chance at winning! We only need 51,419 more signatures to reach the next goal – can you help?

Category:

Activism, Lyme, Testing, vaccines